Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic review

Capecitabine is widely used in the management of metastatic breast cancer; however, drug delivery is limited by gastrointestinal and other toxicity. We employed mathematical modeling to rationally design an optimized dose and schedule for capecitabine of 2,000 mg twice daily, flat dosing, 7 days on,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cadoo, Karen A, Gajria, Devika, Suh, Emily, Patil, Sujata, Theodoulou, Maria, Norton, Larry, Hudis, Clifford A, Traina, Tiffany A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515341/
https://www.ncbi.nlm.nih.gov/pubmed/28721374
http://dx.doi.org/10.1038/npjbcancer.2016.6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515341/
https://www.ncbi.nlm.nih.gov/pubmed/28721374
http://dx.doi.org/10.1038/npjbcancer.2016.6

Ejemplares similares